MEDIVIR AB - INTERIM REPORT JANUARY
/PRNewswire/ -- Preparations for the planned phase 2b study continue according to plan after the completed Type C meeting with the FDA, strengthened by the...
Source: prnewswire.com
Hallberg Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hallberg Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hallberg Management Today - Breaking & Trending Today
MEDIVIR AB - INTERIM REPORT JANUARY - MARCH 2024
STOCKHOLM, April 30, 2024 /PRNewswire/ — Preparations for the planned phase 2b study continue according to plan after the completed Type C meeting with the FDA, strengthened by the fact that the median time to progression with fostrox + Lenvima increased to 7 months. January – March Financial summary for the quarter Net turnover amounted to […]
Source: bubblear.com
MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2023
/PRNewswire/ -- "The clinical efficacy of fostrox in combination with Lenvima continues to improve with median time to progression having increased to over 6...
Source: prnewswire.com
Medivir carries out a directed share issue of approx. SEK 20 million
/PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) ("Medivir" or the "Company"), a pharmaceutical company focused on developing innovative treatments for...
Source: prnewswire.com